Retreatment of Direct Acting Agents (DAAs) After Initial DAA Failure in Hepatitis C Patients
Retreatment with SOF/VEL + RBV, GLE/PIB for 12 weeks, or SOF/LDV achieved high SVR12 rates, indicating that effective viral eradication is feasible using currently available DAA regimens even after prior treatment failure.
Authors
- Yasuhiro Asahina (ORCID: https://orcid.org/0000-0002-9900-0064)
- Tatsuya Kanto
- Hiroyuki Marusawa
- Hideki Fujii
- Masayuki Kurosaki
- Hironori Ochi
- Takuya Sho
- Nobuharu Tamaki
- Namiki Izumi
- Hayato Hikita
- Yuichiro Suzuki
Institutions
- Tokyo Medical and Dental University (JP)
- Osaka University of Economics (JP)
- Hokkaido University (JP)
- Osaka City University (JP)
- National Center for Global Health and Medicine (JP)
- Matsuyama Red Cross Hospital (JP)
- Kyoto first Red Cross hospital (JP)
- Musashino Red Cross Hospital (JP)
- Osaka Red Cross Hospital (JP)
- University of Yamanashi (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Hepatology Research
- Published
- 2026-01-29
- DOI
- https://doi.org/10.1111/hepr.70128
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science